Adial Pharmaceuticals, Inc. (ADIL) NASDAQ

0.24

-0.0072(-2.92%)

Updated at December 24 01:00PM

Currency In USD

Valuation

Market Cap18.77M
Enterprise Value15.02M
P/E Ratio-0.66
PEG Ratio-0.02
Price/Sales Ratio10,183.45
Price/Book Ratio1.18
Enterprise/Revenue2,016.27
Enterprise/EBITDA-0.14

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-14,276.24
Operating Margin-13,926.98

Management Effectiveness

Return On Assets-1.42
Return On Equity-1.98

Income Statement

Revenue0
Revenue/Share0
Gross Profit0
EBITDA-8.28M
Net Income-13.2M
Diluted EPS-0.71

Balance Sheet

Total Cash4.61M
Total Cash/Share0.21
Total Debt0
Total Debt/Equity0
Current Ratio4.34
Book Value Per Share0.2

Price History

52-Week Change-77.2
52-Week High1.3
52-Week Low0.22
Moving Average 50 Days0.32
Moving Average 200 Days0.46

Statistics

Average Volume494,101
Shares Outstanding23.99M
% Held by Institutions5.72

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:25
Last Split DateAugust 07, 2023